How Defect Size, Location, and OA Stage Drive the Choice

When a scan report shows a focal cartilage defect in the hip, three pieces of information determine whether OATS, AMIC, or OCA is the appropriate repair: the size of the lesion, where it sits on the joint surface, and how far any surrounding osteoarthritis has progressed.

Defect size sets the primary boundary. Lesions under 2 cm² on the femoral head are generally within the range of OATS, which uses the patient's own osteochondral plug harvested from a low-load zone of the same joint. Mid-sized defects of roughly 2–4 cm² — most commonly on the acetabular surface in the context of femoroacetabular impingement syndrome (FAIS) — favour AMIC, a single-stage arthroscopic procedure combining microfracture with a collagen scaffold. Larger defects, or those involving subchondral bone collapse from avascular necrosis, typically exceed what autograft can cover, making fresh osteochondral allograft transplantation (OCA) the only viable biological option.

Location matters independently of size. Acetabular lesions arising from FAIS carry the strongest published evidence for AMIC; femoral-head lesions from trauma, Perthes disease, or avascular necrosis more often require OATS or OCA, usually delivered through a surgical hip dislocation approach.

OA stage is the overriding filter. A Tönnis grade of 2 or above — indicating moderate to severe joint-space narrowing — renders all three biological repair procedures ineffective; joint replacement becomes the appropriate discussion at that point. The clinical importance of this threshold is reflected in who actually undergoes these procedures: German epidemiological data covering 116,179 hip cartilage operations between 2006 and 2022 recorded an average patient age of just 27.73 years — a cohort with decades ahead of them and an intact enough joint to justify preservation.

OATS for Small Focal Defects on the Femoral Head

For patients with a small, well-defined lesion on the femoral head, OATS — osteochondral autograft transfer, sometimes called mosaicplasty — takes a self-sourced approach to repair. Bone-and-cartilage plugs are harvested from a non-weight-bearing region of the patient's own femoral head and press-fitted into the damaged area, bringing living hyaline cartilage into a zone that can no longer repair itself.

Because the graft material comes from the same hip, there is no waiting for a donor tissue match. The practical trade-off is a ceiling on defect size: a multicenter comparative study placed mean autograft defect dimensions at 1.6 × 1.0 cm, considerably smaller than the lesions typically addressed by fresh allograft. Once a defect outgrows what a single or mosaic arrangement of plugs can cover, autograft supply runs out before the repair is complete.

Access to the femoral head usually requires a surgical hip dislocation — a controlled technique in which the hip is carefully dislocated and then reduced, allowing the surgeon a direct view of the joint surface. Durability data from the same multicenter series are reassuring: patients who received autograft plugs achieved a mean modified Harris Hip Score of approximately 87, and none showed radiographic osteoarthritis progression at a mean follow-up of 9.5 years. A separate case series reported Harris Hip Score improvement from 62 pre-operatively to 92 at 5.5 years following OATS for osteochondritis dissecans after Legg-Calvé-Perthes disease.

Donor-site morbidity — the possibility of mild discomfort or minor surface irregularity at the harvest zone — is a genuine consideration that a consultant should discuss before surgery, though published series generally report it as a manageable limitation rather than a major source of post-operative difficulty.

AMIC for Mid-Sized Acetabular and Femoral Defects

Where the defect falls into the 2–4 cm² mid-range — most commonly on the acetabular surface in the context of FAIS — AMIC offers something basic microfracture cannot: a structural scaffold that holds the marrow clot in place and guides it towards hyaline-like tissue rather than the softer, less durable fibrocartilage that microfracture alone tends to produce. The technique was first described as a fully arthroscopic approach in the hip in 2012; working through the arthroscope rather than through surgical hip dislocation removes the avascular necrosis risk that open access carries.

The procedure combines microfracture of the subchondral bone with immediate application of a bi-layer type I/III collagen membrane (Chondro-Gide) in a single operative stage — no second procedure is needed to implant cells or retrieve a separate graft.

Although direct head-to-head RCT data comparing AMIC, OATS, and OCA specifically in the hip are limited, the cohort-level evidence for AMIC is now substantial. A 2025 systematic review and meta-analysis pooling 628 hips reported a pooled success rate of 99.6% and a mean mHHS improvement of approximately 36 points. A 2024 systematic review of 209 hips placed pre-operative mHHS between 44.5 and 62.8, rising to 78.8–95.8 post-operatively. The most clinically striking comparison is THA conversion: across comparative studies, zero AMIC patients required total hip arthroplasty, versus up to 32.6% in matched microfracture-alone controls. An updated 27-study review placed AMIC survival between 92.9% and 100%, compared with 59.1%–100% for isolated microfracture — a tighter range that reflects consistent rather than variable benefit.

In a cohort of 62 recreational athletes treated arthroscopically for mid-sized acetabular defects, mean HOOS rose from 58.8 to 90.6 and patients returned to recreational sport by two years, reinforcing AMIC's suitability for the active younger patients who form the majority of this clinical group.

OCA for Large or Post-Collapse Femoral-Head Defects

Fresh osteochondral allograft — OCA — becomes the relevant option when a defect is simply too large for autograft plugs to fill, or when subchondral collapse from avascular necrosis, osteochondritis dissecans following Perthes disease, or significant trauma has left a void that no other restorative technique can address.

In practice, lesions reaching OCA are substantially larger than those treated by OATS. A 2025 series of 24 patients treated via surgical hip dislocation reported a mean defect area of 488 mm² — roughly three times the footprint of the typical autograft case. A matched cadaveric femoral-head allograft is prepared and implanted to restore both the bony and cartilaginous layers in a single stage; the logistical requirement for suitable donor tissue affects surgical timing.

Functional results from that series were meaningful: mHHS improved from 62.1 to 83.9, and iHOT-12 from 35.5 to 77.5, with 67–76% of patients reaching the minimum clinically important difference. The honest counterpoint is that 25% had converted to total hip arthroplasty at a mean of 3.8 years — a higher figure than either OATS or AMIC carry. A multicenter autograft-versus-allograft comparison reinforces this pattern: despite similar mHHS scores of approximately 87 in both groups, 21.1% of OCA recipients required THA at a mean of 1.9 years, whereas none of the autograft patients showed radiographic osteoarthritis progression at nearly a decade of follow-up.

OCA is therefore best understood as a genuine joint-preservation strategy for carefully selected patients — typically young adults with Tönnis grade 0–1, where defect size or anatomy leaves no lesser reconstructive option — rather than a routine first choice. The functional gains are real even for those who ultimately proceed to replacement at a later stage.

OA Stage as the Overriding Eligibility Criterion

The Tönnis system grades hip osteoarthritis severity from 0 to 3 using plain X-ray findings. Grade 0 shows a normal joint with no OA signs; grade 1 indicates minor changes — a slight reduction in joint space, perhaps a small osteophyte or a localised area of increased bony density. Grade 2 introduces definite joint-space narrowing, early subchondral cysts, and more pronounced osteophytes. Grade 3 describes severe OA: large cysts, gross joint-space loss, and possible femoral-head deformity.

The contraindication at grade ≥2 is biological rather than procedural convention. OATS, AMIC, and OCA each depend on healthy surrounding cartilage and competent subchondral bone to achieve stable integration. In a joint already under the mechanical stress of progressive OA, neither a graft nor a scaffold can consolidate reliably before the adjacent tissue degrades further — the repair environment, not merely the defect itself, must be capable of supporting healing.

This makes the treatment window genuinely narrow. Patients identified at grade 0 or 1 — typically in their twenties or thirties — remain candidates for joint-preserving repair. Those who arrive at grade 2 or beyond are better served by hip replacement planning: at that point, biological repair cannot reverse the wider joint deterioration, and attempting it would not change the eventual outcome. Early assessment before OA becomes established is therefore one of the clearest reasons prompt imaging and specialist review matter in this age group.

Recovery, Monitoring, and When to Seek Assessment

Recovery from all three procedures is measured in months, not weeks. Protected weight-bearing is standard immediately after surgery, followed by a structured programme to rebuild hip strength and range of motion. The clearest return-to-sport benchmark comes from the AMIC recreational-athlete cohort: participants resumed recreational activity at around two years post-operatively. OATS and OCA, both requiring surgical hip dislocation rather than an arthroscopic approach, carry broadly comparable or longer recovery trajectories.

Post-operative cartilage monitoring has a standardised framework: the MERCH score evaluates repair tissue across seven MRI domains — including defect fill, surface integrity, integration, and subchondral changes — at a minimum of 12 months post-operatively using 3.0T MRI. Structured MERCH-based follow-up remains underutilised in routine UK practice; patients preparing for any of these procedures may find it useful to ask their surgeon explicitly about a planned imaging review at the appropriate interval.

For a younger patient with unresolved hip pain and a focal defect on imaging, the most consequential step is specialist review before OA reaches Tönnis grade 2 and the surgical window closes. Lincolnshire Hip is part of the MSK Doctors group, accepts patients without a GP referral, and offers assessment locally in Sleaford and Grantham. Seeking that review early is what keeps the full range of joint-preserving options on the table.

1. [1] Osteochondral Allograft and Autograft Transplant for Femoral Head Defects: A Multicenter Study. (2025). https://doi.org/10.1177/03635465251338062 https://doi.org/10.1177/03635465251338062
2. [2] A novel technique for treating cartilage defects in the hip: a fully arthroscopic approach to using autologous matrix-induced chondrogenesis. (2012). https://doi.org/10.1016/j.eats.2012.02.003 https://doi.org/10.1016/j.eats.2012.02.003
3. [3] Hip articular cartilage repair with autologous mesenchymal stem cells (MSCs): 4-year results in prospective controlled study. (2025). https://doi.org/10.1093/jhps/hnaf011.025 https://doi.org/10.1093/jhps/hnaf011.025
4. [4] Defining hip cartilage repair: a modified Delphi study to establish the MERCH score. (2023). https://doi.org/10.1186/s40634-023-00676-y https://doi.org/10.1186/s40634-023-00676-y
5. [5] Outcomes of Arthroscopic Joint Preservation Techniques for Chondral Lesions of the Hip: An Updated Systematic Review. (2023). https://doi.org/10.1016/j.arthro.2023.11.019 https://doi.org/10.1016/j.arthro.2023.11.019
6. [6] Autologous Matrix-Induced Chondrogenesis for the Treatment of Hip Acetabular Chondral Lesions Demonstrates Improved Outcomes: A Systematic Review. (2024). https://doi.org/10.1016/j.arthro.2024.04.028 https://doi.org/10.1016/j.arthro.2024.04.028
7. [7] Trends in Cartilage Repair Techniques for Chondral Defects in the Hip in Germany: An Epidemiological Analysis from 2006 to 2022. (2024). https://doi.org/10.3390/life14101262 https://doi.org/10.3390/life14101262
8. [8] Osteochondral Allograft Transplantation of the Femoral Head via Surgical Hip Dislocation: Survivorship and Patient Reported Outcome Measures at Minimum 2-Year Follow-Up. (2025). https://doi.org/10.1177/23259671251385115 https://doi.org/10.1177/23259671251385115
9. [9] Preserving Hip Stability Yields Better Cartilage Repair With Microfracture Treatment: A Rabbit Study. (2025). https://doi.org/10.1016/j.asmr.2025.101284 https://doi.org/10.1016/j.asmr.2025.101284